Are Climate-Driven Shifts in Bat Diversity to Blame for COVID-19?

A study proposes that habitat for bats—and their accompanying coronaviruses—has increased in southern Asia over the last century, but experts debate the reliability of the analysis.

Written byAsher Jones
| 4 min read
Yunnan province, China, bats, bat, COVID-19, SARS-CoV-2, SARS-CoV-1, infectious disease, pandemic, coronavirus, climate change, modeling,

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK, VONKARA1

Most evidence scientists have generated since the start of the pandemic points to bats as the likely source of the COVID-19–causing coronavirus. A shift in the global distribution of the winged mammals due to climate change may be responsible for recent disease outbreaks, according to a study published January 26 in Science of The Total Environment.

The authors of the paper estimate that bat diversity increased the most in an area that includes Myanmar, Laos, and southern China—where SARS-CoV-2 likely originated—thereby increasing the chances of a bat-borne disease spreading to humans.

“Our estimates add to previous studies that have highlighted the effect that climate change can have on the global distribution of pathogen-carrying wildlife,” Robert Beyer, a research fellow at the Potsdam Institute for Climate Impact Research in Germany and the lead author of the study, tells The Scientist in an email. “We know that these ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies